![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at the 25th Annual ROTH Conference
12 mars 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 12, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 25TH Annual ROTH Conference at 3:30 PM PT on Tuesday, March...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2012 Results
07 mars 2013 16h17 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 7, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year ended December 31,...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Receives FDA Guidance for a Northera(TM) (Droxidopa) NDA Resubmission With Study 306B
20 févr. 2013 07h00 HE
|
Chelsea Therapeutics
Company to Resubmit NDA in Late Second Quarter 2013
Short-term Clinical Benefit Adequate to Support Approval
Company to Host Conference Call Today at 9:00 AM ET
CHARLOTTE,...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces Northera(TM) (Droxidopa) Study 306B Meets Primary Endpoint
04 déc. 2012 16h05 HE
|
Chelsea Therapeutics
Northera™ Demonstrated Statistically Significant Improvement Over Placebo in Reduction of Dizziness/Lightheadedness at Week 1 (p=0.018), the Primary Endpoint, and Standing Blood Pressure at...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Reports Third Quarter 2012 Financial Results
07 nov. 2012 16h16 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the quarter and nine months ended September 30,...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces Results From Northera(TM) (droxidopa) Study in Spinal Cord Injury at the 23rd International Symposium on the Autonomic Nervous System
06 nov. 2012 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced results from a study of Northera™ (droxidopa) in hypotensive individuals...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at the 14th Annual Rodman & Renshaw Global Healthcare Investment Conference
04 sept. 2012 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 14th Annual Rodman & Renshaw Global Healthcare Investment...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference
08 août 2012 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Reports Second Quarter 2012 Financial Results
07 août 2012 16h13 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the quarter and six months ended June 30, 2012.
For the...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Implement Corporate Reorganization
10 juil. 2012 06h45 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 10, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that its Board of Directors plans to promptly implement a corporate...